Vitrafy Life Sciences Limited (ASX:VFY)
Australia · Delayed Price · Currency is AUD 1.760
0.00 (0.00%)
At close: Feb 10, 2026
Vitrafy Life Sciences Company Description
Vitrafy Life Sciences Limited engages in the research, development, and commercialization of cryopreservation solutions in Australia.
The company offers smart devices, such as smart cryopreservation, smart thawing, and smart packaging devices.
It also provides a software platform, which controls, trace, tracks, and monitors quality of cryopreserved biomaterials under the LifeChain brand.
The company’s cryopreservation technology is used various applications, such as blood platelets, cell and gene therapies, and aquaculture and bovine breeding programs.
Vitrafy Life Sciences Limited was incorporated in 2017 and is based in Melbourne, Australia.
Vitrafy Life Sciences Limited
| Country | Australia |
| Founded | 2017 |
| Industry | Laboratory Apparatus and Furniture |
| Employees | 22 |
| CEO | Brenton Michael Owens |
Contact Details
Address: 385 Bourke Street Melbourne, VIC 3000 Australia | |
| Phone | 61 3 9692 7222 |
| Website | vitrafy.com |
Stock Details
| Ticker Symbol | VFY |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| SIC Code | 3821 |
Key Executives
| Name | Position |
|---|---|
| Brenton Michael Owens | Chief Executive Officer |
| Simon Martin | Chief Financial Officer |